Member Info for dsaf

Computer, you really are a bout of negative idiocy.

If they cannot sell to the DHSC they will sell all they make to the private market and a much greater margin.

What was the question and answer? Sorry didn't get chance to watch presentation.

They are actively looking into biodegradable plastics.

I assume your not invested.. your literally that one cloud that hangs around on a sunny day.. no one cares you here and no one gives a **** if you burn away.

In the bin you go.

TWATcher have a day off mate..

Made a right hash of the post, sorry all.

Thu, 22nd Apr 2021 07:00

RNS Number : 2769W
Avacta Group PLC
22 April 2021

THE INFORMATION COMMUNICATED WITHIN THIS ANNOUNCEMENT IS DEEMED TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014. UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.





22 April 2021



Avacta Group plc

("Avacta", the "Group" or the "Company")



Preliminary Results for the year ending 31 December 2020



Significant progress in Diagnostics and Therapeutics Divisions



Avacta Group plc (AIM: AVCT), the developer of diagnostics and innovative cancer therapies based on its proprietary Affimer® and pre|CISION™ platforms, is pleased to announce its preliminary results for the year ending 31 December 2020.



Operating highlights



Operating highlights - Diagnostics

· Rapid generation of a range of Affimer® reagents that bind the SARS-CoV-2 coronavirus spike antigen for diagnostic testing applications.

· Collaboration with several partners to develop a rapid test for the COVID-19 infection for mass population screening.

· Appointed BBI Solutions, part of BBI Group ('BBI'), and Abingdon Health to manufacture the saliva-based rapid SARS-CoV-2 antigen test.

· Entered a collaboration with the Liverpool School of Tropical Medicine ('LSTM') to provide analytical and clinical validation of the rapid coronavirus antigen test.

· Announced launch of an ELISA laboratory test for the SARS-CoV-2 spike protein to support global research efforts into the coronavirus that causes COVID-19.

· Collaboration with Adeptrix (Beverly, MA, USA) to develop a high throughput Affimer-based SARS-CoV-2 antigen bead-assisted mass spectrometry test ('BAMSTM' test) to be used on hospitals' existing installed base of mass spectrometers to diagnose COVID-19 infection. Initiated clinical evaluation of BAMS™ SARS-CoV-2 antigen test at a UK NHS hospital site.

· Exclusive distribution agreement announced with Medusa19 Limited ('Medusa19') for direct-to-consumer sales of a rapid antigen self-test for Covid-19.

· Major licensing agreement with Astrea Bioseparations Limited ('Astrea') for the use of the Affimer® platform in affinity purification applications.

· Successfully passed first audit by the Group's Notified Body (BSI Group) of the Company's Quality Management System as first step in establishing ISO13485 accreditation, a critical quality assurance system for a developer and legal manufacturer of diagnostic products and medical devices. The final audit will take place in April 2021.

· Strengthened and expanded diagnostics management team with the appointment of a Product Manager, Head of Product Development and Operations Director.





Post-period highlights - Diagnostics

· AffiDX® SARS-CoV-2 Antigen Lateral Flow Test shows excellent analytical sensitivity of 50 pg/ml of S1 spike protein with a read time of

Thankyou much appreciated.

Good evening,

Is it possible to watch the webinar online somewhere?

Many thanks

.. and you sold your £200 when Gary?

Here here.

75/76 even more zzzzzzzzz

BC and GDR on it.

Computer must he very cold out there tonight under your bridge. Why don't you hug the other trolls and keep warm.

There is zero need for personal attacks no matter who they are aimed at. In the bin you go.

Oddly enough frequent flights from bournemouth to Seoul and back , but strangely same plane has also done a couple of trips recently to New york -

Those flights are by Maleth Aero, they are PPE flights not tests.

Dont put money on that.. they are being shipped south all the time.. and still being flown into LHR.

is there a definitive way , that we can ascertain that the government have FINALLY stopped ordering this ****ty chinese text?

I know a chap on twitter who's a pilot and he's said there's another 30 flights booked in rammed full of rebranded innova junk. He's never once been wrong previously on all the flights that run into Doncaster Sheffield Aiport.

I've done my research thankyou and i'm balls deep with £175k invested. Directors can sell at anypoint they wish for any reason they want, but only in alloted time frames governed by the FCA but being fully researched you'd already know that.

Your attacking bigjock, with the whole insider information drivel, craig isn't privy to anything we dont know as Colin would not risk jeopardising the NDA he is currently under, fact.

If your being attacked, filter them.. you have the option the same as everyone else, but in this case its "oh well they attacked me so im allowed to attack them".. give over, be the better man and just filter or walk away rather then getting the final word in.

Colin has openly said they remain in discussion finalising the contract, I even have it in black and white from him. May I suggest you stop being so pedantic and learn to take things on the fly, your very "share-polar" on minute your all for ODX then the next your fully against whilst attacking other users. Seriously, take a break.

You know half of you on this board should be ashamed to be human. What utter drivel some of you spout, personal attacks and more. I think you all need to seriously grow up and learn how to respect one another.

Hi Folks,

I'm not a holder of NCYT but just wanted to wish all those who have had losses today, no matter how big or small the best going forward.. I hope it recovers and bounces sufficient for you guys to be able to claw some back.